Abstract:Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas systems have been harnessed as powerful genome editing tools in diverse organisms. However, the off-target effects and the protospacer adjacent motif (PAM) compatibility restrict the therapeutic applications of these systems. Recently, a <em>Streptococcus pyogenes</em> Cas9 (SpCas9) variant, xCas9, was evolved to possess both broad PAM compatibility and high DNA fidelity. Through determination of multiple xCas9 structures, which are all in complex with single-guide RNA (sgRNA) and double-stranded DNA containing different PAM sequences (TGG, CGG, TGA, and TGC), we decipher the molecular mechanisms of the PAM expansion and fidelity enhancement of xCas9. xCas9 follows a unique two-mode PAM recognition mechanism. For non-NGG PAM recognition, xCas9 triggers a notable structural rearrangement in the DNA recognition domains and a rotation in the key PAM-interacting residue R1335; such mechanism has not been observed in the wild-type (WT) SpCas9. For NGG PAM recognition, xCas9 applies a strategy similar to WT SpCas9. Moreover, biochemical and cell-based genome editing experiments pinpointed the critical roles of the E1219V mutation for PAM expansion and the R324L, S409I, and M694I mutations for fidelity enhancement. The molecular-level characterizations of the xCas9 nuclease provide critical insights into the mechanisms of the PAM expansion and fidelity enhancement of xCas9 and could further facilitate the engineering of SpCas9 and other Cas9 orthologs.

A Cas9 with PAM recognition for adenine dinucleotides

An Engineered ScCas9 with Broad PAM Range and High Specificity and Activity.

Evolved Cas9 variants with broad PAM compatibility and high DNA specificity

PAM-Flexible Genome Editing with an Engineered Chimeric Cas9.

Engineer Chimeric Cas9 to Expand PAM Recognition Based on Evolutionary Information

Expanding PAM recognition and enhancing base editing activity of Cas9 variants with non‐PI domain mutations derived from xCas9

Engineered CRISPR-Cas9 nuclease with expanded targeting space

Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease

Fine-Tuning Cas9 Activity with a Cognate Inhibitor AcrIIA4 to Improve Genome Editing in <i>Streptomyces</i>

Cas9-orthologue-mediated cytosine and adenine base editors recognizing NNAAAA PAM sequences

An engineered ScCas9 with broad PAM range and high specificity and activity (vol 85, pg 613, 2020)

Domain-inlaid Nme2Cas9 adenine base editors with improved activity and targeting scope

Exploring and engineering PAM-diverse Streptococci Cas9 for PAM-directed bifunctional and titratable gene control in bacteria

Engineered CRISPR-Cas9 nucleases with altered PAM specificities

Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants

Hybrid Cas12a Variants with Relaxed PAM Requirements Expand Genome Editing Compatibility

Engineering Nme2Cas9 Adenine Base Editors with Improved Activity and Targeting Scope

Construction of non-canonical PAM-targeting adenosine base editors by restriction enzyme-free DNA cloning using CRISPR-Cas9

Genome editing with natural and engineered CjCas9 orthologs

SaCas9 Requires 5'-NNGRRT-3' PAM for Sufficient Cleavage and Possesses Higher Cleavage Activity Than SpCas9 or FnCpf1 in Human Cells.

Programming PAM antennae for efficient CRISPR-Cas9 DNA editing